Thyas

company

About

Thyas provides preparations of regenerative immunocell therapy for cancer and infection.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥240M
Industries
Health Care,Medical,Therapeutics
Founded date
Aug 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥240M
Thyas has raised a total of ¥240M in funding over 2 rounds. Their latest funding was raised on Nov 20, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 20, 2019 Series Unknown ¥240M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Thyas is funded by 1 investors. Chuo Shinkin Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Chuo Shinkin Venture Capital Series Unknown